Evoke Pharma (NASDAQ:EVOK) Shares Cross Below 200 Day Moving Average of $6.68

Shares of Evoke Pharma, Inc. (NASDAQ:EVOK) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $6.68 and traded as low as $5.19. Evoke Pharma shares last traded at $5.27, with a volume of 7,950 shares.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Evoke Pharma in a research note on Thursday. They issued a “sell” rating on the stock.

Evoke Pharma Price Performance

The firm has a market cap of $47.28 million, a P/E ratio of -3.01 and a beta of 0.38. The stock’s 50-day simple moving average is $6.18 and its two-hundred day simple moving average is $6.64.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($2.04) EPS for the quarter. Evoke Pharma had a negative return on equity of 4,908.09% and a negative net margin of 116.75%. The firm had revenue of $1.74 million for the quarter.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.